Paul Daly (Fianna Fail) | Oireachtas source

I will take up one point Dr. Woods made. He stated four out of every ten doctors in the UK have indicated the possibility of moving on or leaving. What detrimental effect would that have? While we are here to formulate a report and steer matters from this side, the UK's problems are not our problems but they are our problems. I was intrigued by that. Did they give reasons as to why they indicated that?

I will elaborate on the Chairman's question on the problems these organisations foresee with regard to regulation, in particular, drug regulation, drug standards and new drugs perhaps being accepted in a new UK and not here. Irrespective of the cross-Border issues they mentioned, what issues may arise in that regard? In the greater scheme of things down the line, what is the possibility of certain drugs not being available in the North which would be available, accessible or sanctioned in the South, or vice versa, and can they see that creating problems for those with rare diseases in one jurisdiction wanting to access such drugs from the other?